SR
SCOTT RANDAL W. disclosed sale in BridgeBio Pharma Inc
SCOTT RANDAL W. disclosed a sale transaction in BridgeBio Pharma Inc (BBIO) on 2026-05-19.
Action
Sale
Capital
$103,164 reported value
Insider Form 4 Activity1 evidence source
Why it matters
This signal is anchored to the Form 4 disclosure date from Dataroma insider data.